| 01 Sept, 04:22 pm | procedural | 0 | The company dispatched the Annual Report 2025-26 and Notice of the 45th AGM (scheduled for September 21, 2026) to members who have not registered their email addresses with the company or depository participants. | nse |
| 01 Sept, 03:31 pm | rating_action | 1 | CARE Ratings reaffirmed its CARE AA / Stable rating on long-term bank facilities (enhanced from 557.50 to 785.00 crore) and CARE AA / Stable / CARE A1+ on long-term/short-term bank facilities (enhanced from 1,348.00 to 1,563.00 crore), with a stable outlook. | nse |
| 28 Aug, 08:37 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Reg. 34 (1) Annual Report. | bse |
| 12 Aug, 06:35 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Aug, 06:30 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 08 Aug, 10:20 am | — | … | Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 08 Aug, 10:18 am | — | … | Update on USFDA inspection at our formulations facility located at Sanand, Ahmedabad, Gujarat, India. | nse |
| 06 Aug, 09:59 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 06 Aug, 09:56 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 06 Aug, 03:19 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange that Record date as September 04, 2026, for the purpose of Final Dividend for the financial year ended March 31, 2026, subject to approval of members. | nse |
| 06 Aug, 03:10 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Intimation Of Date Of The 45Th Annual General Meeting And Record Date | bse |
| 06 Aug, 02:09 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 06 Aug, 02:08 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 06 Aug, 01:59 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 06 Aug, 01:56 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 06 Aug, 01:51 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026 | bse |
| 06 Aug, 01:42 pm | — | … | Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 06 Aug, 01:40 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026 | bse |
| 22 Jul, 06:13 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited.'. | nse |
| 21 Jul, 03:53 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 21 Jul, 03:49 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 20 Jul, 04:20 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 20, 2026, titled "Emcure to Expand the Use of Poviztra® for MASH Indication Following CDSCO Approval". | nse |
| 20 Jul, 04:18 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 Jul, 06:26 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026 | bse |
| 13 Jul, 04:45 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 13, 2026, titled "Press Release titled Emcure Consolidates Gennova Ownership; Sharpens Focus on Biologics; Samit Mehta Leads the Next Phase of Growth ". | nse |
| 13 Jul, 04:43 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Jul, 04:24 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition | nse |
| 13 Jul, 04:22 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 11 Jul, 10:29 am | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Sale or disposal | nse |
| 11 Jul, 10:26 am | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Restructuring | bse |
| 03 Jul, 10:14 am | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition | nse |
| 03 Jul, 10:02 am | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 30 Jun, 05:57 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 30 Jun, 05:51 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 24 Jun, 05:18 pm | — | … | Satish Mehta, Sunil Mehta, Samit Mehta and Namita Thapar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 12 Jun, 09:59 am | investor_meet | 1 | Emcure Pharmaceuticals Limited informed the exchange about an investor presentation. | nse |
| 27 May, 08:01 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 70000 securities pursuant to ESOP/ESPS at its meeting held on May 27, 2026 | nse |
| 27 May, 06:03 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 20 May, 04:34 pm | — | … | Intimation of schedule of Analyst/ Investor Meeting(s) on May 27, 2026 | nse |
| 16 May, 02:57 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 16 May, 02:49 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Inspection At Our Formulations Facility Located At Sanand, Ahmedabad, Gujarat, India. | bse |
| 11 May, 06:18 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 11 May, 06:16 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 08 May, 01:16 pm | — | … | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Rating | nse |
| 06 May, 06:24 pm | — | … | Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026 | nse |
| 05 May, 08:20 pm | — | … | Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 05 May, 08:18 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 May, 03:58 pm | — | … | Revised intimation of Change in Management with minor correction in cover letter | nse |
| 05 May, 03:46 pm | — | … | Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 05 May, 03:09 pm | — | … | Re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company and Mr. Satish Mehta as Managing Director of the Company | nse |